207 related articles for article (PubMed ID: 31117166)
21. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
22. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
[TBL] [Abstract][Full Text] [Related]
23. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.
Gravina GL; Mancini A; Colapietro A; Vitale F; Vetuschi A; Pompili S; Rossi G; Marampon F; Richardson PJ; Patient L; Patient L; Burbidge S; Festuccia C
Tumour Biol; 2017 Jun; 39(6):1010428317695528. PubMed ID: 28639900
[TBL] [Abstract][Full Text] [Related]
24. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
Rempel SA; Dudas S; Ge S; Gutiérrez JA
Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
[TBL] [Abstract][Full Text] [Related]
25. CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner.
Gibbs C; So JY; Ahad A; Michalowski AM; Son DS; Li Y
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012586
[TBL] [Abstract][Full Text] [Related]
26. Chemokine CXCL14; a double-edged sword in cancer development.
Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
[TBL] [Abstract][Full Text] [Related]
27. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
28. [Expression of chemokine CXCL14 in primary osteosarcoma and its association with prognosis].
Lu J; Wang J; Yong B; Song G; Zhao Z; Tang Q; Zou C; Yin J; Xie X; Shen J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):798-803. PubMed ID: 23803187
[TBL] [Abstract][Full Text] [Related]
29. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
30. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
[TBL] [Abstract][Full Text] [Related]
31. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
32. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F
Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969
[TBL] [Abstract][Full Text] [Related]
33. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
34. Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion.
Zhao L; Wang Y; Xue Y; Lv W; Zhang Y; He S
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):890-8. PubMed ID: 26390883
[TBL] [Abstract][Full Text] [Related]
35. Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma.
Parikh A; Shin J; Faquin W; Lin DT; Tirosh I; Sunwoo JB; Puram SV
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958684
[TBL] [Abstract][Full Text] [Related]
36. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract][Full Text] [Related]
37. The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.
Westrich JA; Vermeer DW; Colbert PL; Spanos WC; Pyeon D
Mol Carcinog; 2020 Jul; 59(7):794-806. PubMed ID: 32212206
[TBL] [Abstract][Full Text] [Related]
38. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
39. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
[TBL] [Abstract][Full Text] [Related]
40. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected].
Izukuri K; Suzuki K; Yajima N; Ozawa S; Ito S; Kubota E; Hata R
Transgenic Res; 2010 Dec; 19(6):1109-17. PubMed ID: 20333465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
